J Pater
About
In The Last Decade
J Pater
16 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 561
- Pathology and Forensic Medicine 354
- Surgery 336
- Hepatology 211
Countries citing papers authored by J Pater
This map shows the geographic impact of J Pater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Pater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Pater more than expected).
Fields of papers citing papers by J Pater
This network shows the impact of papers produced by J Pater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Pater. The network helps show where J Pater may publish in the future.
Co-authorship network of co-authors of J Pater
This figure shows the co-authorship network connecting the top 25 collaborators of J Pater. A scholar is included among the top collaborators of J Pater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Pater. J Pater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 39 | |
| 3 | 1 | |
| 4 | Do patients with obstructive sleep apnea have clinically significant proteinuria? | 18 |
| 5 | 143 | |
| 6 | Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer. breakdown → | 789 |
| 7 | 404 | |
| 8 | Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee. | 13 |
| 9 | 63 | |
| 10 | 113 | |
| 11 | Modeling toxicity and response in carboplatin-based combination chemotherapy. | 22 |
| 12 | 27 | |
| 13 | 5 | |
| 14 | 45 | |
| 15 | Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy. | 12 |
| 16 | 2 | |
| 17 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.